Wall Street Journal -- Despite soaring revenue, Aurora Diagnostics Inc. is on track to post an unprofitable year, according to nine-month figures released this week in the company’s latest initial public offering prospectus.
Wall Street Journal -- Despite soaring revenue, Aurora Diagnostics Inc. is on track to post an unprofitable year, according to nine-month figures released this week in the company’s latest initial public offering prospectus.
